Lv5
840 积分 2025-08-18 加入
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer
1小时前
待确认
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
1小时前
已完结
Cancer incidence and mortality in China, 2022
1小时前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
1小时前
已完结
Breast Cancer Statistics, 2022
1小时前
待确认
Ecotypes of triple-negative breast cancer in response to chemotherapy
22天前
已完结
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
1个月前
已完结
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study
1个月前
已完结
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
1个月前
已完结
Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancer
1个月前
已关闭
皖公网安备34019202002308
